ENDRA Life Sciences Inc
NDRA - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.12M
Close$
$0.34
92.8% downside
Current Fair Value
92.8% downsideOvervalued by 92.8% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $7.12 Million |
|---|---|
| Enterprise Value | $5.81 Million |
| Earnings per Share | $-8.93 |
| Beta | -0.07 |
| Outstanding Shares | 1,324,046 |
Return
| Return on Equity | -93.77% |
|---|---|
| Return on Assets | -74.50% |
| Return on Invested Capital | -22.30% |
Valuation & Multiples
| P/E Ratio | -0.75 |
|---|---|
| PEG | 0.66 |
| Price to Sales | - |
| Price to Book Ratio | 1.19 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -3.64 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 17, 2026
EPS Estimate
$-1.14
Consensus analyst estimateRevenue Estimate
$100,000
Consensus analyst estimateNext Earnings Call
Expected Date
November 13, 2026
EPS Estimate
$-0.84
Consensus analyst estimateRevenue Estimate
$100,000
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About ENDRA Life Sciences Inc
18 employees
